Drug Metabolism Reviews
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.7 | Q1 | 78.4% | 0.930 | Q1 | 81.9% |
| 2024 | 3.8 | Q2 | 74.2% | 1.044 | Q1 | 85.3% |
| 2023 | 3.4 | Q2 | 71.3% | 0.870 | Q1 | 82.1% |
| 2022 | 5.9 | Q1 | 88.7% | 1.003 | Q1 | 86.3% |
| 2021 | 7.0 | Q1 | 90.9% | 0.984 | Q1 | 86.2% |
| 2020 | — | — | 1.023 | Q1 | 85.8% | |
| 2019 | — | — | 1.119 | Q1 | 88.0% | |
| 2018 | — | — | 0.944 | Q1 | 82.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0360-2532
ISSN
1097-9883
country
GBcoverage
1972, 1974-2026